This study sought to describe influenza vaccination coverages for different Spanish population subgroups, stressing the analysis of vaccination-related factors in subjects aged 50-64 years and estimating the possible beneficial effect of extending universal vaccination to this age group. A total of 6,400 surveys, targeting subjects over the age of 16 years and drawn from the 1997 Spanish National Health Survey, were used for study purposes. Influenza coverage was observed to rise significantly with age, and the reason cited by most subjects for seeking vaccination was medical indication. Coverage of the 50-64 age group was 21.6% (95% CI 19.4-23.8) and the variables associated with a greater probability of being vaccination were: residence in towns or cities with <10,000 inhabitants (OR 1.45); monthly income of less than 600 (OR 1.71); and presence of associated chronic disease (OR 3.07.) It is estimated that in Spain, 524,514 (40.7%) persons aged 50-64 years with associated chronic disease receive and 764,218 persons aged 50-64 years with associated chronic disease do not receive influenza vaccine. We conclude that the extremely high number of subjects in the 50-64 age range susceptible to influenza-related complications each year constitutes good grounds for universal vaccination being extended to said age group.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0264-410x(03)00425-0 | DOI Listing |
Vaccines (Basel)
January 2025
Department of Family and Geriatric Nursing, Faculty of Health Sciences, Medical University of Lublin, Staszica 6 Str., PL-20-081 Lublin, Poland.
Background: Vaccination is one of the most effective ways of protecting individuals against serious infectious diseases and their fatal consequences.
Objectives: The aim of this scoping review was to synthesize data on parental attitudes toward vaccination and identify factors influencing the motivators and barriers to children's vaccination based on Polish studies.
Methods: The scoping review process and reporting were based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScRs) checklist.
Vaccines (Basel)
December 2024
College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA 99202, USA.
Background/objectives: Rural communities in the United States experience increased disparity of care for both general healthcare services and access to routine vaccines. Previous research has indicated a 40% lower vaccination rate in rural communities, as compared to urban counterparts. Having a better understanding regarding factors influencing lower vaccination rates in rural areas could help public health officials prepare for future vaccination efforts.
View Article and Find Full Text PDFAm J Mens Health
December 2024
Department of Infectious Diseases and Clinical Microbiology, Bolu Abant Izzet Baysal University, Bolu, Turkey.
This descriptive, cross-sectional survey study aimed to evaluate the knowledge of human papillomavirus (HPV) infection and vaccination, related diseases, vaccination status, and attitudes toward vaccination among Turkish male health care workers (HCWs). The study was planned between June 20 and 30, 2023. A questionnaire was developed by reviewing similar studies to assess the sociodemographic characteristics, knowledge about HPV, vaccination, and attitudes toward vaccination.
View Article and Find Full Text PDFFront Psychiatry
November 2024
Centre for Psychiatry Research (CPF), Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Introduction: Vaccination-related conspiracy ideation is related to reduced compliance with public health advice globally. Such beliefs have previously been linked to the delusion-proneness trait. However, it is not known how this extends to getting vaccinated.
View Article and Find Full Text PDFMod Rheumatol
November 2024
Immuno-Rheumatology Center, St Luke's International Hospital, Tokyo, Japan.
Objectives: We studied the current state and factors associated with the acceptance or hesitancy of booster doses of the coronavirus disease 2019 (COVID-19) vaccine among patients with autoimmune and rheumatic diseases (ARDs) in Japan.
Methods: A single-center cross-sectional survey was conducted among outpatients with ARDs who visited the Immuno-Rheumatology Center at St. Luke's International Hospital from 1 October to 30 November in 2023.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!